WE’RE SCIENTISTS IN
THE BUSINESS OF
Southern Research Drug Development
Southern Research Drug Development provides commercial and government clients with a wide variety of nonclinical and clinical trial support services. We offer an array of studies including both in vitro and in vivo testing of small molecule compounds, vaccines, biologics and other test articles in therapeutic areas, such as infectious disease, CNS and cancer.
Our nationally recognized team of dedicated individuals provides expertise and services spanning from basic research to advanced studies under FDA GLP regulations.
Drug Development Services
How To Work With Us
As a CRO service provider, Southern Research’s Drug Development division has a straightforward business model. Contact our business development representative by clicking here. A confidentiality disclosure agreement will be initiated (your agreement or ours) to facilitate detailed discussions around your specific needs. One of our subject matter experts will be brought into the discussion to ensure we have a comprehensive understanding of your project. A proposal will then be prepared, outlining the tasks to be accomplished, along with a budget and timeline. Upon acceptance of the proposal, a contract will be provided to establish the legal framework for the project.
Drug Development News
College students from across the U.S. are getting firsthand experience with the innovative work conducted at Southern Research in the latest generation of the nonprofit’s internship program. Interns from Princeton…
Southern Research has been awarded a new, five-year Indefinite-Delivery Indefinite-Quantity (IDIQ) contract from the National Cancer Institute to investigate the pharmacokinetic properties of antitumor and other therapeutic agents of interest…
Southern Research scientists joined the front lines in the battle against HIV/AIDS in 1986, not long after the deadly viral infection emerged as a terrifying new public health threat in…
In a message to mark Southern Research’s 75th anniversary, Dr. Francis S. Collins, director of the National Institutes of Health, praised the organization’s scientists for making significant advances against cancer…